Vermillion & White Wealth Management Group »

Acrivon Therapeutics shares owned by Vermillion & White Wealth Management Group

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Vermillion & White Wealth Management Group from 13F filings

Historical chart of Vermillion & White Wealth Management Group investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Vermillion & White Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Vermillion & White Wealth Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $44k 18k 2.41

More positions owned by Vermillion & White Wealth Management Group

Ishares Core S&p 500 Etf Uie (IVV)
Dimensional Intern Core Eqt Mkt Etf Uie (DFAI)
Dimensional Core Fixed Income Etf Uie (DFCF)
Astoria Us Quality Growth Kings Etf Uie (GQQQ)
Astoria Us Equal Wt Qlt Kings Etf Uie (ROE)
Dimensional Emerg Core Eqy Mrkt Etf Uie (DFAE)
Dimensional Shrt Drt Fxdincm Etf Uie (DFSD)
St Strt Spdr Prtfl Intdttm Tsry Etf Uie (SPTI)
Ea Astoria Dynmc Cre Us Fxd Incm Etf Uie (AGGA)
Invsc Kbw Bank Etf Uie (KBWB)
Astoria Real Assets Etf Uie (PPI)
Ishares Flexible Incme Active Etf Uie (BINC)
Microsoft Corporation (MSFT)
Apple (AAPL)
Doubleline Mortgage Etf Uie (DMBS)

View all positions for Vermillion & White Wealth Management Group

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Marshall Wace
Acorn Capital Advisors
UBS Group
Jane Street
Two Sigma Investments
BlackRock
Geode Capital Management
Millennium Management

View all funds holding Acrivon Therapeutics